Viewing Study NCT00045734


Ignite Creation Date: 2025-12-25 @ 2:18 AM
Ignite Modification Date: 2026-01-03 @ 11:11 AM
Study NCT ID: NCT00045734
Status: COMPLETED
Last Update Posted: 2017-05-15
First Post: 2002-09-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Imatinib Mesylate in Treating Patients With Recurrent Meningioma
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult Grade I Meningioma View
None Adult Grade II Meningioma View
None Adult Grade III Meningioma View
None Adult Meningeal Hemangiopericytoma View
None Adult Meningioma View
None Recurrent Adult Brain Tumor View
Keywords: